CD200 mimetic aptamer PEG-M49 markedly increases the therapeutic effects of pegylated liposomal doxorubicin in a mouse model of metastatic breast carcinoma: an effect independent of CD200 receptor 1. [electronic resource]
Producer: 20200214Description: 103-114 p. digitalISSN:- 1432-0851
- Animals
- Antigens, CD -- genetics
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Aptamers, Nucleotide -- pharmacology
- Breast Neoplasms -- drug therapy
- Cell Line, Tumor
- Disease Models, Animal
- Doxorubicin -- analogs & derivatives
- Drug Synergism
- Female
- Humans
- Mice
- Mice, Inbred BALB C
- Mice, Knockout
- Orexin Receptors -- genetics
- Polyethylene Glycols -- pharmacology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.